Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Experimental tumor therapy].

× No keyword cloud information.

21 in total

1. Prognostic value of HIF-1α expression during fractionated irradiation.

Authors: L Helbig; A Yaromina; S N Sriramareddy; S Böke; L Koi; H D Thames; M Baumann; D Zips
Journal: Strahlenther Onkol Date: 2012-09-29 Impact factor: 3.621

2. Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts.

Authors: Ala Yaromina; Theresa Kroeber; Andreas Meinzer; Simon Boeke; Howard Thames; Michael Baumann; Daniel Zips
Journal: Int J Radiat Oncol Biol Phys Date: 2011-04-12 Impact factor: 7.038

3. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

Authors: S Nasu; K K Ang; Z Fan; L Milas
Journal: Int J Radiat Oncol Biol Phys Date: 2001-10-01 Impact factor: 7.038

4. Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Authors: Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina
Journal: Strahlenther Onkol Date: 2011-04-26 Impact factor: 3.621

5. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

Authors: Ala Yaromina; Daniel Zips; Howard D Thames; Wolfgang Eicheler; Mechthild Krause; Andrea Rosner; Michael Haase; Cordula Petersen; James A Raleigh; Verena Quennet; Stefan Walenta; Wolfgang Mueller-Klieser; Michael Baumann
Journal: Radiother Oncol Date: 2006-09-07 Impact factor: 6.280

6. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

Authors: L Milas; K Mason; N Hunter; S Petersen; M Yamakawa; K Ang; J Mendelsohn; Z Fan
Journal: Clin Cancer Res Date: 2000-02 Impact factor: 12.531

7. Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.

Authors: Mechthild Krause; Gernot Ostermann; Cordula Petersen; Ala Yaromina; Franziska Hessel; Andreas Harstrick; Albert J van der Kogel; Howard D Thames; Michael Baumann
Journal: Radiother Oncol Date: 2005-08 Impact factor: 6.280

Review 8. Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.

Authors: Klaus Dittmann; Claus Mayer; H Peter Rodemann
Journal: Strahlenther Onkol Date: 2009-12-28 Impact factor: 3.621

Review 9. Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors.

Authors: Mechthild Krause; Kristin Gurtner; Yvonne Deuse; Michael Baumann
Journal: Int J Radiat Biol Date: 2009-11 Impact factor: 2.694

Review 10. PET imaging of tumour hypoxia.

Authors: Anwar Padhani
Journal: Cancer Imaging Date: 2006-10-31 Impact factor: 3.909

1 in total

1. Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells.

Authors: Henri Wichmann; Antje Güttler; Matthias Bache; Helge Taubert; Swetlana Rot; Jacqueline Kessler; Alexander W Eckert; Matthias Kappler; Dirk Vordermark
Journal: Strahlenther Onkol Date: 2014-08-27 Impact factor: 3.621

1 in total